Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer
JAMA Oncol
.
2020 Apr 1;6(4):585-586.
doi: 10.1001/jamaoncol.2019.6709.
Author
Fa-Chyi Lee
1
Affiliation
1
Division of Hematology/Oncology, Department of Internal Medicine, University of California, Irvine, Orange.
PMID:
32053140
DOI:
10.1001/jamaoncol.2019.6709
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Humans
Neoplasm Recurrence, Local
Receptors, Estrogen
Substances
Receptors, Estrogen